Presentation Type
Poster
Department
Biological Science
Location
Walker Conference Center B
Description
Objective: Type 2 diabetics have a higher prevalence of cardiovascular disease complications (Glovaci et al., 2019). Cardiovascular disease was the cause of death in 9.9% of Type II Diabetics which represents 50.3% of all deaths related to Type II Diabetes Mellitus (Einarson et al., 2017). Across the world, cardiovascular disease affects approximately 32.2% of all people with Type II Diabetes Mellitus (Einarson et al., 2017). This begs the question: in individuals with type 2 diabetes, does medication education on Sodium-Glucose Co-Transporter 2 inhibitors, or SGLT-2 inhibitors, and Glucagon-Like Peptide-1 Agonists, or GLP-1 agonists, increase patient compliance with medication by medication education? Methods: A literature review was conducted using the Boolean strategy, including the words “AND”, “OR”, and “BUT” in Google Scholar and PubMed search engines. The following filters included: “5 years ago,” “nursing interventions,” “evidence-based research,” and “peer-reviewed.”
Results: Four articles were selected for review and they included two meta-analyses of randomized control groups, a cross-sectional study, and a literature review. Three articles showed that SLGT-2 inhibitors had some preventative effects on cardiovascular events, but no significant benefits were found in protecting people with type II diabetes from cardiovascular complications (Nelinson et al., 2021, Palmer et al., 2021, Sayour et al., 2024). The literature review stated that patients educated on medications are more likely to adhere to them, (Nelinson et al., 2021).
Discussion: Therefore, there was not enough research to show that adherence to these antidiabetic medications decreased the risk of cardiovascular disease complications in type 2 diabetics. However, research does show that medication education improves medication adherence. Therefore, this evidence should be utilized in nursing because medication education leads to increased compliance with client medication regimens. Nurses should educate the clients on the medications they are giving and the provider’s orders at discharge. If this is implemented, there will likely be a higher success rate in clients complying with and finishing their medications. Adherence to these medications may not drastically reduce cardiovascular disease complications, but it will decrease risk in Type 2 Diabetics who comply with their medications.
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
Included in
Patient Compliance Through Education for Type 2 Diabetics on New Medications: SGLT-2 Inhibitors and GLP-1 Analogues
Walker Conference Center B
Objective: Type 2 diabetics have a higher prevalence of cardiovascular disease complications (Glovaci et al., 2019). Cardiovascular disease was the cause of death in 9.9% of Type II Diabetics which represents 50.3% of all deaths related to Type II Diabetes Mellitus (Einarson et al., 2017). Across the world, cardiovascular disease affects approximately 32.2% of all people with Type II Diabetes Mellitus (Einarson et al., 2017). This begs the question: in individuals with type 2 diabetes, does medication education on Sodium-Glucose Co-Transporter 2 inhibitors, or SGLT-2 inhibitors, and Glucagon-Like Peptide-1 Agonists, or GLP-1 agonists, increase patient compliance with medication by medication education? Methods: A literature review was conducted using the Boolean strategy, including the words “AND”, “OR”, and “BUT” in Google Scholar and PubMed search engines. The following filters included: “5 years ago,” “nursing interventions,” “evidence-based research,” and “peer-reviewed.”
Results: Four articles were selected for review and they included two meta-analyses of randomized control groups, a cross-sectional study, and a literature review. Three articles showed that SLGT-2 inhibitors had some preventative effects on cardiovascular events, but no significant benefits were found in protecting people with type II diabetes from cardiovascular complications (Nelinson et al., 2021, Palmer et al., 2021, Sayour et al., 2024). The literature review stated that patients educated on medications are more likely to adhere to them, (Nelinson et al., 2021).
Discussion: Therefore, there was not enough research to show that adherence to these antidiabetic medications decreased the risk of cardiovascular disease complications in type 2 diabetics. However, research does show that medication education improves medication adherence. Therefore, this evidence should be utilized in nursing because medication education leads to increased compliance with client medication regimens. Nurses should educate the clients on the medications they are giving and the provider’s orders at discharge. If this is implemented, there will likely be a higher success rate in clients complying with and finishing their medications. Adherence to these medications may not drastically reduce cardiovascular disease complications, but it will decrease risk in Type 2 Diabetics who comply with their medications.
Comments
This poster was presented in partial fulfillment of the Evidence Based Research (NURS 3133) course taught by Dr. Carol Carter.